Towa Pharmaceutical Co., Ltd. announced that at the conclusion of the 68th ordinary general meeting to be held on June 25, 2024, Norikazu Eiki plans to resign as an Outside Director who is an Audit and Supervisory Committee Member. Norikazu Eiki satisfies requirements for an independent officer as provided for by the Tokyo Stock Exchange Inc. If his election is approved, the Company plans to designate him as an independent officer. Norikazu Eiki (April 17, 1948) - Career summary: August 1979 Joined Ciba-Geigy Japan Limited - January 1994 Joined Bayer Yakuhin, Ltd. - March 1997 Director /Plant Manager of Shiga Plant, Bayer Yakuhin, Ltd. - July 2002 President and Representative Director, Bayer Yakuhin, Ltd. - January 2007 Chairperson and Representative Director, Bayer Yakuhin, Ltd. - April 2010 Chairperson and Director, Bayer Yakuhin, Ltd. - May 2014 Outside Director of AnGes MG Inc. (currently AnGes Inc.) (to present) - April 2015 Outside Director of FunPep Co., Ltd. (to present) - June 2015 Outside Director of the Company - April 2016 Outside Director of Solasia Pharma K.K. (to present) - June 2018 Outside Director of Gene Techno Science Co., Ltd. (currently, Kidswell Bio Corporation) (to present) - June 2019 Outside Director (Audit and Supervisory Committee Member) of the Company (to present) - August 2023 Outside Director of AwakApp Inc. (to present).

At the conclusion of the 68th ordinary general meeting, Masao Tanaka will retire from the Director due to expiration of his term of office. At the conclusion of the 68th ordinary general meeting, Norikazu Inoue plans to resign as a Director who is an Audit and Supervisory Committee Member.